Overview A Double-Blind Study of E5555 in Japanese Subjects With Coronary Artery Disease Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to assess the safety and tolerability of E5555 in Japanese subjects with coronary artery disease. Phase: Phase 2 Details Lead Sponsor: Eisai Co., Ltd.